Identification | Back Directory | [Name]
E3 Ligase Ligand-Linker Conjugates 20 | [CAS]
1950635-15-0 | [Synonyms]
Thalidomide-O-amido-C8-NH2 Cereblon Ligand-Linker Conjugates 2 E3 Ligase Ligand-Linker Conjugates 20 N-(8-aminooctyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide | [Molecular Formula]
C23H30N4O6 | [MDL Number]
MFCD31630819 | [MOL File]
1950635-15-0.mol | [Molecular Weight]
458.51 |
Hazard Information | Back Directory | [Uses]
Thalidomide-O-amido-C8-NH2 (Cereblon Ligand-Linker Conjugates 2), a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs[1]. | [IC 50]
Cereblon | [References]
[1] James Bradner, et al. Methods to induce targeted protein degradation through bifunctional molecules. WO 2017024317 A2. |
|
Company Name: |
Biorbyt Ltd.
|
Tel: |
+44 (0)1223 859 353 |
Website: |
www.biorbyt.com |
|